Active surveillance for recurrent low-grade non-muscle-invasive bladder cancer: Can we take any advantage from the COVID-19 crisis?

References

• Svatek RS , Hollenbeck BK , Holmang S , et al. The economics of bladder cancer: costs and considerations of caring for this disease. Eur Urol. 2014;66:253–262.
   PubMed Web of Science ®Google Scholar
• Bray F , Ferlay J , Soerjomataram I , et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.
   PubMed Web of Science ®Google Scholar
• Sylvester RJ , van der Meijden AP , Oosterlinck W , et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol. 2006;49:466–477.
   PubMed Web of Science ®Google Scholar
• Matulay JT , Soloway M , Witjies A , et al. Risk-adapted management of low-grade bladder tumours: recommendations from the International Bladder Cancer Group (IBCG). BJU Int. 2020;125:497–505.
   Web of Science ®Google Scholar
• Chang SS , Boorjian SA , Chou R , et al. Diagnosis and treatment of non-muscle invasive bladder cancer: AUA/SUO Guideline. J Urol. 2016;196:1021–1029.
   PubMed Web of Science ®Google Scholar
• Babjuk M , Burger M , Compérat E , et al. European association of urology guidelines on non-muscle-invasive bladder cancer, 2020. [cited May 2020]. https://uroweb.org/guideline/non-muscle-invasive-bladder-cancer/
   Google Scholar
• Soloway MS , Bruck DS , Kim SS. Expectant management of small, recurrent, noninvasive papillary bladder tumors. J Urol. 2003;70:438–441.
   Google Scholar
• Dekalo S , Matzkin H , Mabjeesh NJ . Can urologists accurately stage and grade urothelial bladder cancer by assessing endoscopic photographs? J Telemed Telecare. 2018;24:603–607.
   Web of Science ®Google Scholar
• Herr HW , Donat SM , Dalbagni G . Correlation of cystoscopy with histology of recurrent papillary tumors of the bladder. J Urol. 2002;168:978–980.
   PubMed Web of Science ®Google Scholar
• Mariappan P , Lavin V , Phua CQ , et al. Predicting grade and stage at cystoscopy in newly presenting bladder cancers-a prospective double-blind clinical study. Urology. 2017;109:134–139.
   PubMed Web of Science ®Google Scholar
• Hurle R , Pasini L , Lazzeri M , et al. Active surveillance for low-risk non-muscle-invasive bladder cancer: mid-term results from the Bladder cancer Italian Active Surveillance (BIAS) project. BJU Int. 2016;118:935–939.
   PubMed Web of Science ®Google Scholar
• Hurle R , Lazzeri M , Vanni E , et al. Active surveillance for low risk nonmuscle invasive bladder cancer: a confirmatory and resource consumption study from the BIAS project. J Urol. 2018;199:401–406.
   Web of Science ®Google Scholar
• Hurle R , Colombo P , Lazzeri M , et al. Pathological outcomes for patients who failed to remain under active surveillance for low-risk non-muscle-invasive bladder cancer: update and results from the Bladder Cancer Italian Active Surveillance project. Eur Urol Oncol. 2018;1:437–442.
   Web of Science ®Google Scholar
• EAU Guidelines Office . Rapid reaction group. An organisation-wide collaborative effort to adapt the EAU guidelines recommendations to the COVID-19 era. [cited May 2020]. https://uroweb.org/wp-content/uploads/EAU-Guidelines-Office-Rapid-Reaction-Group-An-organisation-wide-collaborative-effort-to-adapt-the-EAU-guidelines-recommendations-to-the-COVID-19-era.pdf
   Google Scholar
• Società Italiana di Urologia . Documento di buona pratica clinica durante emergenza COVID-19. [cited May 2020]. https://www.siu.it/
   Google Scholar
• Stensland KD , Morgan TM , Moinzadeh A . et al. Considerations in the triage of urologic surgeries during the COVID-19 pandemic. Eur Urol;2020. DOI:10.1016/j.eururo.2020.03.027. Epub ahead of print
   Google Scholar